ArticleLeukemia research reports2022

Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation.

R Iannotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.